← Back to patent-cliff list
CAS 1375180-30-5
1-(3-(benzyloxy)propyl)-5-formylindoline-7-carbonitrile
Codes: SILO-052
Application context (from source-drug indications)
Benign prostatic hyperplasiaSilodosinLower urinary tract symptomsSilodosinUrolithiasisSilodosinKidney stonesSilodosinContraceptive useSilodosinUrinary tract stonesSilodosin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Silodosin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
indoline→nitroethane→2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl methanesulfonate→3-chloropropan-1-ol→((3-chloropropoxy)methyl)benzene→1-(3-(benzyloxy)propyl)indoline→1-(3-(benzyloxy)propyl)indoline-5-carbaldehyde→1-(3-(benzyloxy)propyl)-7-bromoindoline-5-carbaldehyde→1-(3-(benzyloxy)propyl)-5-formylindoline-7-carbonitrile→1-(3-(benzyloxy)propyl)-5-(2-nitropropyl)indoline-7-carbonitrile→1-(3-(benzyloxy)propyl)-5-(2-oxopropyl)indoline-7-carbonitrile→(R)-2-methylpropane-2-sulfinamide→(S)-N-(1-(1-(3-(benzyloxy)propyl)-7-cyanoindolin-5-yl)propan-2-yl)-2-methylpropane-2-sulfinamide→(R)-5-(2-aminopropyl)-1-(3-(benzyloxy)propyl)indoline-7-carbonitrile 2-hydroxy-2-phenylacetate→(R)-1-(3-(benzyloxy)propyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carbonitrile→(R)-1-(3-(benzyloxy)propyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.